Search Results - "R. Di Francia"

Focus on the use of Green Tea in cancer setting: between lights and shadows by M. Berretta, R. Di Francia

“…Green tea (GT) is a beverage derived from the unfermented leaves of Camellia sinensis, a plant native to Asia. Green tea extract is marketed as an antioxidant…”
Get full text

Current predictive pathology in the clinical setting of colorectal cancer by Toni, G, Franco, R, Di Francia, R

Get more information

Antioxidant diet and genotyping as tools for the prevention of liver disease by Di Francia, R, Rinaldi, L, Cillo, M, Varriale, E, Facchini, G, D'Aniello, C, Marotta, G, Berretta, M

“…It is well-known that 75% of risk factors of chronic liver disease (CLD) are related to nutrition. These circumstances potentially progress towards liver…”
Get more information

New treatment strategies for HIV-positive cancer patients undergoing anticancer medical treatment: update of the literature by Berretta, M, Facchini, B A, Colpani, A, Di Francia, R, Montopoli, M, Pellicanò, G, Tirelli, U, Fiorica, F, Ottaiano, A, Madeddu, G, De Vito, A

“…The introduction of highly active antiretroviral therapy (ART) has deeply modified the outcome of HIV patients by improving their overall survival and…”
Get more information

Comment on "Tegafur gimeracil oter combined with oxaliplatin for advanced colorectal cancer." Is it cost effectiveness? by Berretta, M, Di Francia, R

Get more information

Effect of anti-oxidant agents in patients with hepatocellular diseases by Di Francia, R, Rinaldi, L, Troisi, A, Di Benedetto, F, Berretta, M

Get more information

Pharmacogenomics as a tool to prevent drug-related hospitalization of elderly cardiology-oncology patients receiving chemotherapeutic agents and multiple symptomatic treatments: a pilot study planned for the Italian health system by Di Francia, R, De Lucia, V, Giordano, A, Benincasa, G, Mignano, M, Berretta, M

“…Current precision medicine approaches offer powerful tools to optimize medication regimens; however, the potential impact of these tools in cancer patients…”
Get more information

Evaluation of genotyping methods and costs for VDR polymorphisms by Di Francia, R, Amitrano, F, De Lucia, D

Get more information

Assessment of pharmacogenomic SLCO1B1 assay for prediction of neuromuscular pain in type 2 diabetes mellitus and cardiovascular patients: preliminary results by Licito, A, Marotta, G, Battaglia, M, Benincasa, G, Mentone, L, Grillo, M R, De Lucia, V, Leonardi, G, Bignucolo, A, Comello, F, Di Francia, R, De Lucia, D

“…At present, several strategies for preventing neuromuscular pain in Type 2 Diabetes Mellitus (T2DM) have been investigated. Recently, findings on genetic…”
Get more information

Validation of a simple genotyping panel assay for pharmacogenomics of taxane-based therapy: preliminary results by A. Vitale, L. Di Francia, D. Costagliola, M. Mignano, A. Luise, M. Di Paolo, S. Pugliese, V. De Lucia, E. Varriale, R. Di Francia

“…Objective: Several strategies for preventing toxicity and resistance to taxane-based chemotherapy have been investigated so far. Lately, findings on the…”
Get full text

Evaluation of genotyping methods and the relative cost of pharmacogenomics by De Monaco, A, Berretta, M, Pugliese, S, Valente, D, Ciaffarafa, S, Di Francia, R

“…Recently, several methods to assess the quality of cost-effectiveness, cost-utility and cost-benefit in the pharmacogenomic field have become available. A…”
Get more information

Personality and psychopathology in patients with temporomandibular joint pain-dysfunction syndrome. A controlled investigation by Meldolesi, G, Picardi, A, Accivile, E, Toraldo di Francia, R, Biondi, M

“…Our aim was to deepen the understanding of the psychosomatic aspects of temporomandibular joint (TMJ) pain dysfunction syndrome. Patients affected by this…”
Get more information

Sorafenib combined with percutaneous radiofrequency ablation for the treatment of medium-sized hepatocellular carcinoma by Berretta, M, Di Francia, R, Tirelli, U

Get more information

The expression of PD-L1 APE1 and P53 in hepatocellular carcinoma and its relationship to clinical pathology by Berretta, M, Stanzione, B, Di Francia, R, Tirelli, U

Get more information

Generation of precise calibration curve for absolute quantification of DNA target by Real-Time PCR. A method for accurate molecular monitoring of t(14;18)-bearing cells in Follicular Lymphoma by R. Di Francia, R. De Filippi, S. Crisci, G. Iaccarino, O. Catapano, E. Varriale, F. Frigeri, A. Pinto

“…Objective: Determination of absolute DNA concentration by Real-Time PCR is mandatory for an accurate molecular diagnosis. The critical step is a precise and…”
Get full text

Knowledge and skills needs for health professions about pharmacogenomics testing field by Di Francia, R, Valente, D, Catapano, O, Rupolo, M, Tirelli, U, Berretta, M

“…Promise in the future, a disease could be ranked into genetic categories, allowing bespoke tailoring of medicine to maximize therapeutic effects and to reduce…”
Get more information

Clinical presentation and outcome of non-AIDS defining cancers, in HIV-infected patients in the ART-era: the Italian Cooperative Group on AIDS and tumors activity by Berretta, M, Martellotta, F, Di Francia, R, Spina, M, Vaccher, E, Balestreri, L, Borsatti, E, Bearz, A, De Paoli, P, Tirelli, U

“…The advent of antiretroviral therapy (ART) has markedly extended the survival rates of patients with human immunodeficiency virus (HIV), leading to suppression…”
Get more information

Multimodal approach of advanced gastric cancer: based therapeutic algorithm by Berretta, S, Berretta, M, Fiorica, F, Di Francia, R, Magistri, P, Bertola, G, Fisichella, R, Canzonieri, V, Tarantino, G, Di Benedetto, F

“…Gastric cancer (GC) is the third leading cause of cancer death in both sexes worldwide, with the highest estimated mortality rates in Eastern Asia and the…”
Get more information

Integrative Medicine in Oncology, Milan October 19th, 2019 by M. Berretta, R. Di Francia, S. Cazzavillan, P. Rossi, A. Scorba, P. Sciacca, D. Santagà

“…Complementary and Alternative Medicine (CAM) interventions are widely used by patients with chronic disorders, including cancer, and may interact with cancer…”
Get full text

A genic and epigenetic combination therapy for liver cancer by Rinaldi, L, Franci, G, Folliero, V, Palomba, L, Isticato, R, Zannella, C, di Francia, R, De Sio, I, Morelli, G, S.Lastoria, Altucci, L, Pedone, C, Ascione, A, Adinolfi, L.E, Galdiero, M

Get full text